Ribon Therapeutics, a clinical-stage biotechnology company developing therapeutics to target stress support pathways, today announced a $25 million in
Media - Abingworth - Abingworth LLP
Ribon Therapeutics Announces $25 Million Equity Investment from Pfizer
424B4
ribon-therapeutics
Leadership – Ribon Therapeutics
Leadership – Ribon Therapeutics
List of top AbbVie Biotech Ventures Portfolio Companies - Recent
TAG: Financing News
Andrew Hirsch 🇺🇸 (@HirschAndrew) / X